59 results on '"Trastuzumab -- Research -- Reports"'
Search Results
2. Reports from St. Marianna University School of Medicine Add New Data to Findings in Breast Cancer [Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib ...]
3. Researchers from Osaka University Describe Findings in Gastric Cancer (Trastuzumab With S-1 Plus Cisplatin In Her2-positive Advanced Gastric Cancer Without Measurable Lesions: Ogsg 1202)
4. Recent Findings in Breast Cancer Described by Researchers from Adnan Menderes University (Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens)
5. Researchers from University of Alabama Detail Findings in Antineoplastic Monoclonal Antibodies [Trastuzumab-Resistant HER2(+) Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition]
6. Researchers from Department of Medical Oncology Report Findings in Biomarkers (Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study)
7. Investigators from University of Buenos Aires Zero in on Stem Cell Research (Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture)
8. Findings on Breast Cancer Reported by Investigators at Weill Cornell Medical College (89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor ...)
9. Findings in Breast Cancer Reported from University of North Carolina School of Medicine (Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer)
10. Investigators at University of Buenos Aires Have Reported New Data on Breast Cancer (Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture)
11. Findings from National University in Breast Cancer Reported (Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab)
12. Researchers from Consejo Nacl Invest Cient and Tecn Report New Studies and Findings in the Area of Breast Cancer (TNF alpha-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer)
13. Researchers from Pennsylvania State University Detail New Studies and Findings in the Area of Breast Cancer (CK0403, a 9-aminoacridine, is a potent anti-cancer agent in human breast cancer cells)
14. Researchers from University of Sheffield Report Recent Findings in Breast Cancer (Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An ...)
15. New Findings on Gastric Cancer Discussed by Researchers at Seoul National University Hospital (Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer)
16. Report Summarizes Breast Cancer Study Findings from Loyola University (PKC alpha Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance)
17. Researchers from Department of Biostatistics Report New Studies and Findings in the Area of Breast Cancer (Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer)
18. Researchers from Zhejiang University Report New Studies and Findings in the Area of Gastric Cancer (Target-specific Delivery of Oxaliplatin To Her2-positive Gastric Cancer Cells In Vivo Using Oxaliplatin-au-fe3o4-herceptin Nanoparticles)
19. Findings from University of Manitoba Provide New Insights into Carcinomas
20. New Biomarkers Findings from University Hospital 12 de Octubre Reported (Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab)
21. Investigators at Cordoba National University Report Findings in Pituitary Cancer (Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway)
22. New Findings in Breast Cancer Described from Yale Cancer Center [Trastuzumab emtansine: determining its role in management of HER2(+) breast cancer]
23. New Findings on Esophagogastric Cancer Reported by J.A. Carrasquillo et al (Pharmacokinetics, Biodistribution, and Radiation Dosimetry for Zr-89-Trastuzumab in Patients with Esophagogastric Cancer)
24. New Breast Cancer Findings from Genentech Described [A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic ...]
25. New Immunoconjugates Study Findings Have Been Reported from University of British Columbia [p-NO2-Bn-H(4)neunpa and H(4)neunpa-Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and In-111 Immuno-Single Photon Emission Computed ...]
26. New Breast Cancer Findings Reported from School of Pharmacy (Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer)
27. Researchers at Genentech Describe Findings in Antineoplastic Monoclonal Antibodies [Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla)]
28. Data on Antineoplastic Monoclonal Antibodies Discussed by Researchers at Seoul National University (Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition)
29. New Antineoplastic Monoclonal Antibodies Findings from University of California Outlined (A New Spin on Antibody Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive Cells)
30. New Findings in Antineoplastic Monoclonal Antibodies Described from Tulane University [Trastuzumab stimulation of ribosomal protein S6 kinase 1 (S6K1) predicts de novo trastuzumab resistance]
31. Researchers from Okayama University Hospital Describe Findings in Non-Small Cell Lung Cancer (Trastuzumab Emtansine in HER2+Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol)
32. Findings from Ohio State University in the Area of Breast Cancer Described (Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells)
33. Studies from H.C. Kolberg et al Add New Findings in the Area of Breast Cancer (Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over ...)
34. Recent Reports from Kyungpook National University Highlight Findings in Breast Cancer [In vitro detection of human breast cancer cells (SK-BR3) using herceptin-conjugated liquid crystal microdroplets as a sensing platform]
35. New Antibiotics Study Findings Reported from University of Pennsylvania (Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction)
36. Kyorin University Reports Findings in Breast Cancer (Abnormal Corneal Lesions Induced by Trastuzumab Emtansine: An Antibody-Drug Conjugate for Breast Cancer)
37. University of Alaska Reports Findings in Breast Cancer (Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells)
38. Reports from Medical University Add New Data to Findings in Tissue Engineering [ErbB2 Blockade with Herceptin (Trastuzumab) Enhances Peripheral Nerve Regeneration after Repair of Acute or Chronic Peripheral Nerve Injury]
39. New Breast Cancer Findings from Weill Cornell Medical College Outlined [Improved Survival of HER2(+) Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain]
40. New Breast Cancer Findings from G. Bernadou and Colleagues Discussed (Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non-metastatic breast cancer)
41. Investigators at University Hospital Report Findings in Breast Cancer (Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer)
42. New Monoclonal Antibodies Findings from Symphogen Discussed (Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance)
43. Research from Southeast University Reveals New Findings on Monoclonal Antibodies (Trastuzumab-cisplatin conjugates for targeted delivery of cisplatin to HER2-overexpressing cancer cells)
44. New Esophagogastric Cancer Study Findings Have Been Reported by K. Merx and Colleagues (Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany)
45. New Findings from Cancer Care of Ontario in Breast Cancer Provides New Insights (The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study)
46. New Findings on Breast Cancer from Red Cross Hospital Summarized (Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor ...)
47. Researchers from Ankara Numune Training and Research Hospital Report Recent Findings in Naphthacenes (Which Sequence Best Protects the Heart Against Trastuzumab and Anthracycline Toxicity? An Electron Microscopy Study in Rats)
48. Findings on Immunoglobulins Reported by Investigators at Genentech [Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate]
49. Findings from University of Tampere Yields New Findings on Breast Cancer (Trastuzumab emtansine: mechanisms of action and drug resistance)
50. New Findings from University of Milan in Breast Cancer Provides New Insights (Trastuzumab-containing regimens for metastatic breast cancer)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.